News & Announcements
Read the latest news from the Bluhm Cardiovascular Institute's Clinical Trials Unit to learn about our recent discoveries, successes, faculty achievements and honors.
CT scans are better at predicting a middle-aged person’s risk for a heart disease, such as a heart attack, than genetics, reports a new Northwestern Medicine study published in JAMA.
From 1999 through 2020, Black Americans experienced more than 1.6 million excess deaths and more than 80 million excess years of life lost compared to white Americans, according to a recent study published in JAMA.
An informational communications tool provided to patients with dilated cardiomyopathy helped increase cardiovascular screenings in their first-degree relatives who have a higher risk of developing the genetic disease, according to findings published in Circulation.
Scientists led by Northwestern University and the University of Texas at Austin (UT) have developed the first cardiac implant made from graphene, a two-dimensional super material with ultra-strong, lightweight and conductive properties, described in a study published in Advanced Materials.
The recommendation to reach 10,000 steps a day has long been the gold standard for staying fit and improving heart health. But new research suggests that it might not be the magic number after all.
Scientists have identified new genes linked to heart failure, according to a study published in Nature Communications.
Integrating social determinants of health helped mitigate bias when predicting long-term outcomes for heart failure patients, according to a Northwestern Medicine study.
A new study has shown that vitamin D supplements do not reduce muscle pain associated with statin drugs.
A study led by Northwestern Medicine investigators found that education and place of birth significantly contribute to racial and ethnic differences in cardiovascular health among U.S. adults.
Susan Quaggin, MD, has been presented one of The American Heart Association’s 2022 Distinguished Scientist awards, which honor members who have significantly advanced the understanding of cardiovascular, stroke or brain health.
There is significant variation in the prevalence of obesity among subgroups of Asian American adults, according to a recent Northwestern Medicine study.
Dapagliflozin, a sodium-glucose cotransporter 2 inhibitor, reduced the risk of cardiovascular-related morality and hospitalization in patients with heart failure, regardless of ejection fraction, according to a series of clinical trial reports.
Mortality rates for ischemic heart disease in Asian American subpopulations were found to be more burdensome than previously reported, according to a Northwestern Medicine study published in JAMA Internal Medicine.
A new grant will fund the hiring of 15 new tenure-track faculty, along with tactics to ensure the success of faculty members from underrepresented populations.
Polygenic risk scores demonstrated minimal clinical benefit in predicting long-term coronary heart disease when added to a traditional risk factor model, according to a Northwestern Medicine study.
- Northwestern Awarded First-Ever National Grant to Study Wearables, Stroke Prevention in Patients With Atrial Fibrillation08.29.2022
Northwestern University has been awarded a seven-year grant to study a “pill-in-pocket” strategy to prevent stroke in patients with atrial fibrillation, the most common heart rhythm disorder in adults.
Bigger test panels are better for genetic testing in cardiomyopathy and heart arrhythmias, according to a recent Northwestern Medicine study.
A new study provides evidence that blood epigenetic biomarkers contain “snapshots” of past cardiovascular health exposures and behavior at the molecular level.